NLS Pharmaceutics NLSPW Stock
NLS Pharmaceutics Price Chart
NLS Pharmaceutics NLSPW Financial and Trading Overview
NLS Pharmaceutics stock price | 0.0060 USD |
Previous Close | 0.02 USD |
Open | 0.05 USD |
Bid | 0 USD x 0 |
Ask | 0 USD x 0 |
Day's Range | 0.03 - 0.06 USD |
52 Week Range | 0.01 - 0.17 USD |
Volume | 40.76K USD |
Avg. Volume | 10.58K USD |
Market Cap | N/A |
Beta (5Y Monthly) | -0.532 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
NLSPW Valuation Measures
Enterprise Value | N/A |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | N/A |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | N/A |
Enterprise Value/EBITDA | N/A |
Trading Information
NLS Pharmaceutics Stock Price History
Beta (5Y Monthly) | -0.532 |
52-Week Change | N/A |
S&P500 52-Week Change | N/A |
52 Week High | 0.17 USD |
52 Week Low | 0.01 USD |
50-Day Moving Average | 0.03 USD |
200-Day Moving Average | 0.07 USD |
NLSPW Share Statistics
Avg. Volume (3 month) | 10.58K USD |
Avg. Daily Volume (10-Days) | 17.27K USD |
Shares Outstanding | N/A |
Float | 19.7M |
Short Ratio | N/A |
% Held by Insiders | N/A |
% Held by Institutions | N/A |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | N/A |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | N/A |
Most Recent Quarter (mrq) | N/A |
Next Fiscal Year End | N/A |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | 0% |
Gross Margin | 0% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -132.68% |
Return on Equity (ttm) | N/A |
Income Statement
Revenue (ttm) | N/A |
Revenue Per Share (ttm) | N/A |
Quarterly Revenue Growth (yoy) | N/A |
Gross Profit (ttm) | N/A |
EBITDA | -11795655 USD |
Net Income Avi to Common (ttm) | -12172029 USD |
Diluted EPS (ttm) | N/A |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 897.68K USD |
Total Cash Per Share (mrq) | 0.02 USD |
Total Debt (mrq) | 1.63M USD |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | 0.23 |
Book Value Per Share (mrq) | -0.272 |
Cash Flow Statement
Operating Cash Flow (ttm) | -9684466 USD |
Levered Free Cash Flow (ttm) | -4995114 USD |
Profile of NLS Pharmaceutics
Country | United States |
State | N/A |
City | Zurich |
Address | The Circle 6 |
ZIP | 8058 |
Phone | 41 44 512 21 50 |
Website | https://nlspharma.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | N/A |
NLS Pharmaceutics AG, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD). Its lead product candidates include Quilience to treat excessive daytime sleepiness and cataplexy associated with narcolepsy; and Nolazol for the treatment of ADHD. The company also developing NLS-4, a selective dopamine reuptake inhibitor treatment for the chronic fatigue associated with the symptoms of Long-COVID; NLS-3, a repurposed reverse ester of methylphenidate for treatment of ADHD; NLS-8, a melatonin ML1A receptor agonist for improved scopolamine-induced amnesia; NLS-11, a norepinephrine and dopamine reuptake inhibitor and muscarinic M1, M2, M3 receptor antagonist; and NLS-12, a norepinephrine and dopamine reuptake inhibitor and muscarinic M4 receptor antagonist. It has licensing agreements with NeuroLife-Sciences SAS for use of mazindol for the treatment of ADHD; and Eurofarma Laboratorios S.A. for commercialization and distribution of Nolazol in Latin America. NLS Pharmaceutics AG was incorporated in 2015 and is based in Zurich, Switzerland.
Q&A For NLS Pharmaceutics Stock
What is a current NLSPW stock price?
NLS Pharmaceutics NLSPW stock price today per share is 0.0060 USD.
How to purchase NLS Pharmaceutics stock?
You can buy NLSPW shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for NLS Pharmaceutics?
The stock symbol or ticker of NLS Pharmaceutics is NLSPW.
Which industry does the NLS Pharmaceutics company belong to?
The NLS Pharmaceutics industry is Biotechnology.
How many shares does NLS Pharmaceutics have in circulation?
The max supply of NLS Pharmaceutics shares is 0.
What is NLS Pharmaceutics Price to Earnings Ratio (PE Ratio)?
NLS Pharmaceutics PE Ratio is now.
What was NLS Pharmaceutics earnings per share over the trailing 12 months (TTM)?
NLS Pharmaceutics EPS is 0 USD over the trailing 12 months.
Which sector does the NLS Pharmaceutics company belong to?
The NLS Pharmaceutics sector is Healthcare.